Argentine biotechnology company Stämm has partnered with Israeli cultivated meat producer SuperMeat, supported by mutual investor Varana Capital, to enhance biomanufacturing processes for cultivated chicken. The collaboration will focus on integrating Stämm’s continuous bioprocessing technology, which has shown significant improvements in productivity and cost reductions in stem cell production, into SuperMeat’s production system. The pilot will evaluate how the technology can be applied to cultivated meat, with a focus on muscle fiber growth, elongation, and the formation of mature tissue, aiming to increase production efficiency and enable the creation of structured whole-cut meat products.

SuperMeat, which has achieved cost parity with premium pasture-raised chicken, aims to further refine its process through this partnership. The companies will assess experimental metrics related to cost efficiency and scalability, with findings used to develop economic models for large-scale cultivated meat facilities. The collaboration is seen as a step toward advancing alternative protein manufacturing, driving progress in the cultivated meat industry and potentially informing broader efforts to commercialize cultivated meat at a competitive price point in the growing alternative protein market.